616 related articles for article (PubMed ID: 11059752)
21. Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction.
Wenger RH; Camenisch G; Desbaillets I; Chilov D; Gassmann M
Cancer Res; 1998 Dec; 58(24):5678-80. PubMed ID: 9865721
[TBL] [Abstract][Full Text] [Related]
22. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment.
Papandreou I; Krishna C; Kaper F; Cai D; Giaccia AJ; Denko NC
Cancer Res; 2005 Apr; 65(8):3171-8. PubMed ID: 15833847
[TBL] [Abstract][Full Text] [Related]
23. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells.
Ghafar MA; Anastasiadis AG; Chen MW; Burchardt M; Olsson LE; Xie H; Benson MC; Buttyan R
Prostate; 2003 Jan; 54(1):58-67. PubMed ID: 12481256
[TBL] [Abstract][Full Text] [Related]
24. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
25. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
26. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.
Koshiji M; To KK; Hammer S; Kumamoto K; Harris AL; Modrich P; Huang LE
Mol Cell; 2005 Mar; 17(6):793-803. PubMed ID: 15780936
[TBL] [Abstract][Full Text] [Related]
27. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.
Birner P; Schindl M; Obermair A; Breitenecker G; Oberhuber G
Clin Cancer Res; 2001 Jun; 7(6):1661-8. PubMed ID: 11410504
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
29. Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma.
Matsuyama T; Nakanishi K; Hayashi T; Yoshizumi Y; Aiko S; Sugiura Y; Tanimoto T; Uenoyama M; Ozeki Y; Maehara T
Cancer Sci; 2005 Mar; 96(3):176-82. PubMed ID: 15771621
[TBL] [Abstract][Full Text] [Related]
30. The effects of local anesthetics on cellular hypoxia-induced gene responses mediated by hypoxia-inducible factor 1.
Nishi K; Hirota K; Takabuchi S; Oda S; Fukuda K; Adachi T; Shingu K
J Anesth; 2005; 19(1):54-9. PubMed ID: 15674517
[TBL] [Abstract][Full Text] [Related]
31. Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.
Kondo Y; Hamada J; Kobayashi C; Nakamura R; Suzuki Y; Kimata R; Nishimura T; Kitagawa T; Kunimoto M; Imura N; Hara S
J Urol; 2005 May; 173(5):1762-6. PubMed ID: 15821583
[TBL] [Abstract][Full Text] [Related]
32. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
33. p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia.
Denko NC; Green SL; Edwards D; Giaccia AJ
Exp Cell Res; 2000 Jul; 258(1):82-91. PubMed ID: 10912790
[TBL] [Abstract][Full Text] [Related]
34. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
[TBL] [Abstract][Full Text] [Related]
35. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.
Kominsky SL; Hobeika AC; Lake FA; Torres BA; Johnson HM
Cancer Res; 2000 Jul; 60(14):3904-8. PubMed ID: 10919667
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells.
Higashimura Y; Nakajima Y; Yamaji R; Harada N; Shibasaki F; Nakano Y; Inui H
Arch Biochem Biophys; 2011 May; 509(1):1-8. PubMed ID: 21338575
[TBL] [Abstract][Full Text] [Related]
38. [Hypoxia and tumors: does HIF-1 transcription factor favor tumor growth or hypoxia?].
Vandenbunder B
Bull Cancer; 1998 Oct; 85(10):843-5. PubMed ID: 9835861
[TBL] [Abstract][Full Text] [Related]
39. Induction of p21 by the Wilms' tumor suppressor gene WT1.
Englert C; Maheswaran S; Garvin AJ; Kreidberg J; Haber DA
Cancer Res; 1997 Apr; 57(8):1429-34. PubMed ID: 9108440
[TBL] [Abstract][Full Text] [Related]
40. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
Gooch JL; Herrera RE; Yee D
Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
